Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) for the Treatment of Peripheral Neuropathic Pain: A Randomises, International, Multicentre, Placebo-Controlled, Phenotype-stratified Phase IIa Study

NCT02957851 is registered in ClinicalTrials.gov with Air Liquide Santé International as lead sponsor.

NCT NCT02957851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) for the Treatment of Peripheral Neuropathic Pain: A Randomises, International, Multicentre, Placebo-Controlled, Phenotype-stratified Phase IIa Study
Lead sponsor
Air Liquide Santé International
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2016
Completion date
August 31, 2018
Enrollment
287 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia